{
  "author": {
    "name": "Nick Bonds",
    "webUrl": "/author/profile/nick-bonds/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2021/06/02/vaccine-patent-waivers-a-roadblock-on-the-path-to-normalcy/",
        "title": "Vaccine patent waivers: A roadblock on the path to normalcy",
        "byline": "Nick Bonds",
        "kicker": "Expert Opinion",
        "prettyDate": "June 02, 2021",
        "timeToRead": "11 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/DrugVials.jpg",
          "width": "600",
          "height": "400"
        },
        "authors": [
          {
            "webUrl": "/author/profile/nick-bonds/",
            "name": "Nick Bonds"
          }
        ],
        "kickerNode": [
          {
            "uri": "/expert-opinion/",
            "sectionName": "Expert Opinion"
          }
        ],
        "summary": "Employers relying on the promise of the vaccines to fully reopen will need to be ready to do what they can to keep our progress on track.",
        "body": null
      }
    ]
  }
}